These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19066295)

  • 1. Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study.
    Savastano S; Di Somma C; Angrisani L; Orio F; Longobardi S; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2009 Mar; 94(3):817-26. PubMed ID: 19066295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding.
    Di Somma C; Angrisani L; Rota F; Savanelli MC; Cascella T; Belfiore A; Orio F; Lombardi G; Colao A; Savastano S
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):393-9. PubMed ID: 18194484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost.
    Galtier F; Farret A; Verdier R; Barbotte E; Nocca D; Fabre JM; Bringer J; Renard E
    Int J Obes (Lond); 2006 Jul; 30(7):1104-10. PubMed ID: 16477271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women.
    Savastano S; Belfiore A; Guida B; Angrisani L; Orio F; Cascella T; Milone F; Micanti F; Saldalamacchia G; Lombardi G; Colao A
    J Endocrinol Invest; 2005 Jun; 28(6):509-15. PubMed ID: 16117191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity.
    Shargorodsky M; Fleed A; Boaz M; Gavish D; Zimlichman R
    Int J Obes (Lond); 2006 Nov; 30(11):1632-8. PubMed ID: 16552402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in body composition and insulin sensitivity in severely obese subjects after laparoscopic adjustable silicone gastric banding (LASGB).
    Garrapa GG; Canibus P; Gatti C; Santangelo M; Frezza F; Feliciotti F; Boscaro M; Faloia E
    Med Sci Monit; 2005 Nov; 11(11):CR522-8. PubMed ID: 16258396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic gastric banding and body composition in morbid obesity.
    Guida B; Belfiore A; Angrisani L; Micanti F; Mauriello C; Trio R; Pecoraro P; Falconi C
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):198-203. PubMed ID: 15955468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition changes after laparoscopic adjustable gastric banding: what is the role of -174G>C interleukin-6 promoter gene polymorphism in the therapeutic strategy?
    Di Renzo L; Carbonelli MG; Bianchi A; Iacopino L; Fiorito R; Di Daniele N; De Lorenzo A
    Int J Obes (Lond); 2012 Mar; 36(3):369-78. PubMed ID: 21730965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired skeletal muscle mitochondrial function in morbidly obese patients is normalized one year after bariatric surgery.
    Vijgen GH; Bouvy ND; Hoeks J; Wijers S; Schrauwen P; van Marken Lichtenbelt WD
    Surg Obes Relat Dis; 2013; 9(6):936-41. PubMed ID: 23791452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status.
    Nadler EP; Reddy S; Isenalumhe A; Youn HA; Peck V; Ren CJ; Fielding GA
    J Am Coll Surg; 2009 Nov; 209(5):638-44. PubMed ID: 19854406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.
    Pontiroli AE; Pizzocri P; Librenti MC; Vedani P; Marchi M; Cucchi E; Orena C; Paganelli M; Giacomelli M; Ferla G; Folli F
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3555-61. PubMed ID: 12161474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial.
    Morino M; Toppino M; Bonnet G; del Genio G
    Ann Surg; 2003 Dec; 238(6):835-41; discussion 841-2. PubMed ID: 14631220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up.
    Carey DG; Pliego GJ; Raymond RL
    Obes Surg; 2006 Dec; 16(12):1602-8. PubMed ID: 17217636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits from growth hormone therapy after bariatric surgery.
    Savastano S
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():540-4. PubMed ID: 19550390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year changes in energy expenditure and serum leptin following adjustable gastric banding in obese women.
    Coupaye M; Bouillot JL; Coussieu C; Guy-Grand B; Basdevant A; Oppert JM
    Obes Surg; 2005; 15(6):827-33. PubMed ID: 15978155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
    Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.